Analytical Data
-
基因名
FLJ10769
- Application
-
别名
NAXD. CARKD. FLJ10769. hCG_32552
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A0A7P0T9D8
-
表达区间
1-347aa
-
氨基酸序列
MVTRAGAGTAVAGAVVVALLSAALALYGPPLDAVLERAFSLRKAHSIKDMENTLQLVRNIIPPLSSTKHKGQDGRIGVVGGCQEYTGAPYFAAISALKVGADLSHVFCASAAAPVIKAYSPELIVHPVLDSPNAVHEVEKWLPRLHALVVGPGLGRDDALLRNVQGILEVSKARDIPVVIDADGLWLVAQQPALIHGYRKAVLTPNHVEFSRLYDAVLRGPMDSDDSHGSVLRLSQALGNVTVVQKGERDILSNGQQVLVCSQEGSSRRCGGQGDLLSGSLGVLVHWALLAGPQKTNGSSPLLVAAFGACSLTRQCNHQAFQKHGRSTTTSDMIAEVGAAFSKLFET
-
分子量
63 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FLJ10769 is a recombinant protein that has garnered significant interest in various fields of biomedical research due to its potential roles in cellular processes and disease mechanisms. Initially identified through genomic studies, FLJ10769 has been implicated in several pathways related to cell signaling, metabolism, and immunity. Its exact biological function remains partially understood, but preliminary studies suggest that it may play a crucial role in cell proliferation and differentiation. Research has shown that alterations in the expression of FLJ10769 can correlate with conditions such as cancer and autoimmune diseases, making it a promising target for therapeutic interventions. The recombinant form of this protein allows for more detailed studies, including structure-function analyses and interaction studies with other biomolecules. Additionally, the ability to produce FLJ10769 in a controlled laboratory setting facilitates the development of assays for drug screening and biomarker discovery. Overall, the exploration of FLJ10769 not only enhances our understanding of its biological significance but also provides avenues for innovative approaches in disease treatment and diagnosis.
